163 related articles for article (PubMed ID: 19956022)
1. Fresh frozen plasma and recombinant factor VIIa use in neonates.
Puetz J; Darling G; McCormick KA; Wofford JD
J Pediatr Hematol Oncol; 2009 Dec; 31(12):901-6. PubMed ID: 19956022
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma.
Puetz J; Darling G; Brabec P; Blatny J; Mathew P
Pediatr Blood Cancer; 2009 Dec; 53(6):1074-8. PubMed ID: 19621430
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
Kwon JO; MacLaren R
Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
[TBL] [Abstract][Full Text] [Related]
4. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
Guzzetta NA; Huch S; Fernandez JD; Tosone SR; Miller BE
Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
[TBL] [Abstract][Full Text] [Related]
5. Fresh frozen plasma use in the NICU: a prospective, observational, multicentred study.
Motta M; Del Vecchio A; Perrone B; Ghirardello S; Radicioni M
Arch Dis Child Fetal Neonatal Ed; 2014 Jul; 99(4):F303-8. PubMed ID: 24646616
[TBL] [Abstract][Full Text] [Related]
6. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities.
Abdel-Wahab OI; Healy B; Dzik WH
Transfusion; 2006 Aug; 46(8):1279-85. PubMed ID: 16934060
[TBL] [Abstract][Full Text] [Related]
7. Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances.
Gkiougki E; Mitsiakos G; Chatziioannidis E; Papadakis E; Nikolaidis N
J Pediatr Hematol Oncol; 2013 Apr; 35(3):221-6. PubMed ID: 23511491
[TBL] [Abstract][Full Text] [Related]
8. Interpretation of clotting tests in the neonate.
Pal S; Curley A; Stanworth SJ
Arch Dis Child Fetal Neonatal Ed; 2015 May; 100(3):F270-4. PubMed ID: 25414486
[TBL] [Abstract][Full Text] [Related]
9. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
10. Changes in the Use of Fresh-Frozen Plasma Transfusions in Preterm Neonates: A Single Center Experience.
Houben NAM; Heeger LE; Stanworth SJ; New HV; van der Bom JG; Fustolo-Gunnink S; Lopriore E
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33238649
[TBL] [Abstract][Full Text] [Related]
11. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
[TBL] [Abstract][Full Text] [Related]
12. Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: Effect on conventional coagulation tests and thrombomodulin-modified thrombin generation.
Rassi AB; d'Amico EA; Tripodi A; da Rocha TRF; Migita BY; Ferreira CM; Carrilho FJ; Farias AQ
J Hepatol; 2020 Jan; 72(1):85-94. PubMed ID: 31536747
[TBL] [Abstract][Full Text] [Related]
13. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
Le Roux P; Pollack CV; Milan M; Schaefer A
J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
[TBL] [Abstract][Full Text] [Related]
14. Fresh Frozen Plasma Use in a Neonatal Unit in South Africa.
Raban MS; Harrison MC
J Trop Pediatr; 2015 Aug; 61(4):266-71. PubMed ID: 25920397
[TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
[TBL] [Abstract][Full Text] [Related]
16. Inappropriateness of fresh frozen plasma for abnormal coagulation tests.
Pybus S; MacCormac A; Houghton A; Martlew V; Thachil J
J R Coll Physicians Edinb; 2012; 42(4):294-300. PubMed ID: 23240113
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
[TBL] [Abstract][Full Text] [Related]
18. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M;
Crit Care; 2006; 10(6):R178. PubMed ID: 17184516
[TBL] [Abstract][Full Text] [Related]
19. Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results.
Holland LL; Brooks JP
Am J Clin Pathol; 2006 Jul; 126(1):133-9. PubMed ID: 16753596
[TBL] [Abstract][Full Text] [Related]
20. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
